Hemoglobin A1C as a prognostic factor and the pre-diabetic paradox in patients admitted to a tertiary care medical center intensive cardiac care unit: The Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-6) study group

BACKGROUND: Hemoglobin A1C (HbA1c) is a form of glycated hemoglobin used to estimate glycemic control in diabetic patients. Data regarding the prognostic significance of HbA1c levels in contemporary intensive cardiac care unit (ICCU) patients is limited. METHODS: All patients admitted to the ICCU at...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupu, Lior, Taha, Louay, Farkash, Rivka, Bayya, Feras, Karmi, Mohammad, Steinmetz, Yoed, Shaheen, Fauzi Fadi, Perel, Nimrod, Hamayel, Kamal, Levi, Nir, Maller, Tommer, Karameh, Hani, Lichewitz, Gavriel, Gavish, Dov, Algur, Nurit, Glikson, Michael, Asher, Elad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153197/
https://www.ncbi.nlm.nih.gov/pubmed/35637510
http://dx.doi.org/10.1186/s12933-022-01529-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153197/
https://www.ncbi.nlm.nih.gov/pubmed/35637510
http://dx.doi.org/10.1186/s12933-022-01529-1

Ejemplares similares